Teva Pharma (TEVA) Lowers Quarterly Dividend 75% to $0.085; 1.1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Teva Reports Second Quarter 2017 Financial Results
August 3, 2017 6:30 AM EDTRevenues of $5.7 billion
GAAP EPS loss of $5.94
Non-GAAP EPS of $1.02
2017 business outlook revised to non-GAAP EPS of $4.30 - $4.50
Teva announces second quarter 2017 dividend of 8.5 cents,
down
75% from 34 cents in the first quarter of 2017
JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended June 30, 2017.
Second quarter results were lower than we anticipated due to... More
